Impact of the chronic use of benzodiazepines prescribed for seizure control on the anxiety levels of patients with epilepsy

Epilepsy and Behavior

Volumn 23, Issue 3, 2012, Pages 373-376

  Pizzol, Angélica Dal ^a,b   Martin, Kelin Cristine ^b   Mattiello, Carlo Mognon ^b   de Souza, Ana Cláudia ^b   Torres, Carolina Machado ^a,b   Bragatti, José Augusto ^a,b   Bianchin, Marino Muxfeldt ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Anxiety disorders; Benzodiazepines; Epilepsy; Psychiatric comorbidities

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADD ON THERAPY; ADULT; ANXIETY DISORDER; ARTICLE; BECK ANXIETY INVENTORY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HAMILTON ANXIETY SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RISK FACTOR; SEIZURE; TEMPORAL LOBE EPILEPSY;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANXIETY; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84858281493     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.12.009     Document Type: Article

References (24)

1. Ropper A.H., Brown R.H. Principles of neurology 2005, McGraw-Hill, USA. Edition 8.
2. Jones J.E., Hermann B., Barry J.J., Gilliam F., Kanner A.M., Meador K.J. Clinical assessment of axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci 2005, 17:172-179.
3. Bijl R.V., Ravelli A., Van Zessen G. Prevalence of psychiatric disorder in the general population results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatr Epidemiol 1998, 33:587-595.
4. Tellez-Zenteno J.F., Patten S.B., Jetté N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
5. Bragatti J.A., Torres C.M., Londero R.G., et al. Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews. Epileptic Disord 2010, 12(4):283-291.
6. Bragatti J.A., Torres C.M., Londero R.G., et al. Prevalence of psychiatric comorbidities in temporal lobe epilepsy in a Southern Brazilian population. Arq Neuropsiquiatr 2011, 69(2-A):159-165.
7. Bragatti J.A., Torres C.M., Assmann J.B., et al. Left-sided EEG focus and positive psychiatric family history are independent risk factors for affective disorders in temporal lobe epilepsy. Epilepsy Res 2009, 87(2-3):169-176.
8. Hamid H., Ettinger A.B., Mula M. Anxiety symptoms in epilepsy: salient issues for future research. Epilepsy Behav 2011, 22(1):63-68.
9. Rogawski M.A., Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 2004, 10:685-692.
10. Kanner A.M. Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci 2008, 10:39-45.
11. Lehrner J., Kalchmayr R., Serles W., et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999, 8(2):88-92.
12. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62(2):258-261.
13. Kanner A.M. Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity. Epilepsy Curr 2011, 11(3):90-91.
14. Clobazam has equivalent efficacy to carbamazepine and phenytoin as mono-therapy for childhood epilepsy. Epilepsia 1998, 39:952-959. Canadian Study Group for Childhood Epilepsy.
15. Riss J., Cloyd J., Gates J., Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 2008, 118:69-86.
16. Brodie M.J. Antiepileptic drug therapy the story so far. Seizure 2010, 19:650-655.
17. Kaufman K.R. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav 2011, 21(1):1-11.
18. Montenegro M.A., Cendes F., Noronha A.L.A., et al. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy. Epilepsia 2001, 42(4):539-542.
19. Beyenburg S., Mitchell A.J., Schmidt D., et al. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav 2005, 7(2):161-171.
20. IBGE Cidades IBGE Cidades Available from:, Accessed August, 2009. http://www.ibge.gov.br/cidadesat/default.php.
21. Ledoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
22. De Bianchedi E.T., De Boschan L.S., De Cortiñas L.P., et al. Theories on anxiety in Freud and Melanie Klein: their metapsychological status. Int J Psychoanal 1988, 69(Pt 3):359-368.
23. Mensah S.A., Beavis J.M., Thapar A.K., Kerr M.P. A community study of the presence of anxiety disorder in people with epilepsy. Epilepsy Behav 2007, 11:118-124.
24. Malmgren K., Sullivan M., Ekstedt G., Kullberg G., Kumlien E. Health-related quality of life after epilepsy surgery: a Swedish multi-centre study. Epilepsia 1997, 38:830-838.